Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

West Pharmaceutical Services Inc. buy Citigroup Inc.

Start price
€326.40
08.01.25 / 50%
Target price
€388.28
08.01.26
Performance (%)
-29.93%
Price
€228.50
15:47
Summary
This prediction is currently active. The prediction for West Pharmaceutical Services Inc. disappoints with a performance of -29.93%. Dividends of €0.20 are taken into consideration when calculating the performance. This prediction currently runs until 08.01.26. The prediction end date can be changed by Citigroup_Inc_ at any time. Citigroup_Inc_ has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
West Pharmaceutical Services Inc. -5.112% -5.112%
iShares Core DAX® 0.734% 1.458%
iShares Nasdaq 100 -2.686% -0.146%
iShares Nikkei 225® -2.261% -2.729%
iShares S&P 500 -1.346% 0.467%

Comments by Citigroup_Inc_ for this prediction

In the thread West Pharmaceutical Services Inc. diskutieren
Prediction Buy
Perf. (%) -29.93%
Target price 388.280
Change
Ends at 08.01.26

West Pharmaceutical Services, Inc. (NYSE: WST) is now covered by analysts at Citigroup Inc.. They set a "buy" rating and a $400.00 price target on the stock.
Ratings data for WST provided by MarketBeat